fda decision on tirzepatide Tirzepatide, FDA, and Compounding: Understanding the Current Landscape Breaking News: Compounding Pharmacies Take

YomogidaYMatsuoJIshidaIOtaMNakamuraKAshidaKet alAn fmri investigation into the effects of ketogenic medium-chain triglycerides on cognitive function in elderly adults: A pilot study

GIP Action: Enhances GLP-1s insulin-stimulating effects, reduces fat storage in adipose tissue, and improves the bodys sensitivity to GLP-1 signaling, making the combination significantly more powerful than either hormone alone

Frontiers in Pharmacology, 16, 1613610

Griendling KK, Touyz RM, Zweier JL, Dikalov S, Chilian W, Chen YR, Harrison DG, Bhatnagar A, American Heart Association Council on Basic Cardiovascular Sciences

Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy

Complete non-response often points to receptor-level issues, either genetic polymorphisms that alter GLP-1 receptor binding, or downstream signaling problems that prevent the receptor activation from translating into metabolic changes